Perfection Is Priced In

When the story is great, the business is real, and the market has already decided you win – that’s exactly when ordinary investors should pause.

A commentary on IPOs, narratives, and who the early money is waiting for

There is a moment in every exciting IPO when the story sounds so compelling, the product so obviously good, and the future so clearly bright, that asking about the price feels almost beside the point. That moment is usually the most dangerous one for ordinary investors.

The market does not price what a company is. It prices what a company is expected to become. And when those expectations are sufficiently euphoric, the stock can fall even while the business succeeds; because success was already assumed, and reality is rarely as tidy as a prospectus.

Three companies illustrate this dynamic across very different contexts: an Australian diagnostics company that rode a pandemic wave, a Mexican fast-food chain that became the most talked-about ASX listing in years, and an American aerospace giant preparing what could be the largest public offering in history. In each case, the business is real. The narrative is compelling. And the price reflects a version of the future that has already decided everything goes to plan.

— Case I —

Atomo Diagnostics: The COVID Exit

Atomo Diagnostics (ASX: AT1) listed in April 2020, the first ASX IPO after a six-week pandemic-induced drought. The timing was extraordinary. The company made rapid diagnostic blood tests, had just pivoted to producing COVID-19 test kits, and listed at $0.20 per share into a world desperately hungry for exactly what it made.

The market responded accordingly. On debut day, the stock surged 125% to $0.45. By its second day of trading it had reached $0.52. The narrative was perfect: a homegrown Australian medtech, pandemic-essential products, global demand, and backing from the Bill & Melinda Gates Foundation’s investment vehicle. The story wrote itself.

AT1 — Atomo Diagnostics · The Numbers
IPO price (April 2020)	$0.20
Day 1 close	$0.45  (+125%)
Day 2 close	$0.52
Current price (June 2026)	~$0.029
Change since IPO	−92.5%
Current revenue (FY2025)	$3.79m  (−7.2% YoY)
Current net loss (FY2025)	−$4.97m

 

The COVID tailwind was real, but it was temporary. When rapid testing demand normalised, what remained was a small, unprofitable medical device company with a niche product set and a market cap that had been built for a world that no longer existed. Those who bought on day two at $0.52 are sitting on a loss exceeding 94% today.

The business did not collapse. It continues to operate, to develop products, to generate some revenue. But the price paid at the peak had assumed a version of the future — perpetual pandemic-level demand — that was never going to materialise. Perfection was priced in. Reality was not.

— Case II —

Guzman y Gomez: When the Story Outran the Store Count

Guzman y Gomez (ASX: GYG) listed in June 2024 at $22 per share, Australia’s largest IPO in three years. The pitch was straightforward and genuinely exciting: a premium fast-casual Mexican chain with strong Australian fundamentals, ambitious US expansion plans, and the audacity to invoke McDonald’s as a long-run benchmark. On debut, shares closed at $30, a 36% first-day surge.

The enthusiasm kept going. By February 2025, GYG had reached an all-time high of approximately $46 per share, more than double its IPO price. At that level, the market was pricing a version of GYG in which the US expansion succeeded, the store count compounded for decades, and the brand became a global institution. Every rosy assumption in the prospectus was treated as a floor, not a ceiling.

“The company is executing well, but not as fast as the market is expecting.”

Analyst commentary on GYG’s February 2026 result — as the stock fell 16.5% in a single session on strong revenue growth

Then came the US reality check. Sales momentum in America disappointed. The DoorDash partnership ended. And what followed was a brutal reassessment, not of whether GYG was a good business, but of whether the price had been appropriate for the assumptions baked in. By late March 2026, the stock had fallen 62% from its peak, trading below its original IPO price.

GYG — Guzman y Gomez · The Numbers
IPO price (June 2024)	$22.00
Day 1 close	$30.00  (+36%)
All-time high (Feb 2025)	~$45.99
Recent low (March 2026)	$16.30  (below IPO)
Decline from peak	−62%
12-month network sales	~$1.2B (record)
Australian comp growth	+17.5%

 

Here is the uncomfortable truth that GYG illustrates so clearly: the company posted record revenues. Australian comparable sales grew 17.5%. Management expanded the restaurant network. By almost any operational measure, GYG was executing. The stock fell anyway, because operational execution was already assumed at the price people paid. The only thing that mattered was whether reality exceeded an extraordinarily demanding set of expectations. It didn’t. The market adjusted.

— Case III —

SpaceX: The Grandest Prospectus of All Time

SpaceX confidentially filed for an IPO in April 2026, with reported ambitions that dwarf anything the public markets have seen. Current estimates place the offering at a valuation between $1.5 trillion and $2 trillion, with plans to raise $75 billion, which would make it the largest public offering in history, eclipsing Saudi Aramco’s 2019 listing.

The business itself is genuinely remarkable. SpaceX generated $18.7 billion in revenue for 2025. Starlink, its satellite internet service, contributed $11.4 billion of that, roughly 61% of total revenue, and now serves over 10 million subscribers across 155 countries. The company has completed hundreds of rocket launches, dramatically reduced the cost of access to orbit, and built infrastructure that no competitor can replicate quickly. This is not a speculative startup. The moat is real.

SpaceX · IPO Snapshot (as reported, June 2026)
Targeted IPO valuation	$1.5–$2.0 trillion
Planned capital raise	~$75 billion
FY2025 revenue	$18.7B  (+33% YoY)
Starlink revenue (FY2025)	$11.4B  (61% of total)
FY2025 GAAP net loss	−$4.94B
Q1 2026 net loss	−$4.28B
Revenue multiple at $1.75T	~93× 2025 revenue
Elon Musk voting control	85% of votes

 

And yet. At $1.75 trillion, SpaceX would be valued at approximately 93 times its 2025 revenue, a GAAP loss-making company, with $4.28 billion in losses in Q1 2026 alone. The valuation is not a reflection of what SpaceX is today. It is a reflection of what the market has decided SpaceX will become: the dominant global internet infrastructure provider, a Mars colonisation company, the backbone of a multi-planetary civilisation. These are not impossible outcomes. But they are outcomes that have to be achieved, not outcomes that are guaranteed.

The Starlink average revenue per subscriber actually fell 18% between 2023 and 2025, as the company traded unit economics for subscriber volume. In May 2026, prices were raised to begin recovering that ground. This is fine, it is a coherent strategy. But it means the extraordinary margin profile that justifies a $2 trillion valuation is still largely ahead of the company, not behind it.

“By the time you’re hearing about it at a barbecue, you are not early. You are the person the early money has been waiting for.”

And then there is Musk concentration risk. 85% of voting control sits with one person who simultaneously runs Tesla, xAI, and various other ventures. This is not a risk that appears in a DCF model. It is a volatility premium that public markets will price in ways that secondary private transactions, conducted among sophisticated, long-term holders, never had to.

— The Framework —

Who Is Selling, and Why Now?

The most useful question any investor can ask when approaching an IPO is not “is this a good business?” It is: who is selling, and why are they selling to me at this price?

In almost every significant IPO, the answer is the same. Founders, early employees, and venture capital investors who participated in the company’s private growth phase, who held through the hard years, the pivots, the near-death moments, are now offering public investors the opportunity to buy in. They do this, quite rationally, at the point of maximum narrative momentum. The story has never been cleaner. The trajectory has never looked better. The prospectus has never been more polished.

That is not cynicism. It is simply how capital markets work. But it means that public investors are, by structural design, later entrants than the people selling to them. The question is not whether that matters; it does, but whether the price reflects adequate compensation for that disadvantage. In frothy IPOs, it usually does not.

Atomo was priced for a permanent pandemic. GYG was priced for a flawless US rollout. SpaceX, if it lists near $1.75 trillion, will be priced for Starlink dominating global internet, Starship achieving its cost targets, and no significant execution stumbles for at least a decade. All of these things might happen. None of them are guaranteed. And the market will be unforgiving the moment reality diverges from the assumed trajectory, even if, as with GYG, that divergence amounts to “executing well, but not quite fast enough.”

What This Means in Practice

None of this means IPOs are always bad investments, or that excitement about a company is irrational. GYG remains a genuinely good fast-food operator. SpaceX has achieved things that seemed impossible a decade ago. Atomo developed technology that demonstrably improves healthcare access in low-resource settings.

The problem is never the business. The problem is the price paid for the business, relative to a realistic assessment of the range of futures it might inhabit. Great businesses at inflated prices produce mediocre or negative returns. Mediocre businesses at the right price can produce excellent ones.

For Australian investors specifically, a SpaceX listing adds further layers of complexity beyond valuation: US market access requirements, currency exposure between AUD and USD, US withholding tax on any dividends, and the question of whether such a speculative, high-concentration holding is appropriate within a properly diversified portfolio — and whether it fits within an investment strategy documented in a Statement of Advice.

The BBQ is a wonderful place to find enthusiasm. It is not a reliable place to find a margin of safety.